These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3941489)

  • 1. New quinolone generation active over wide spectrum.
    Riesenberg DE
    JAMA; 1986 Jan; 255(2):176. PubMed ID: 3941489
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmid-mediated resistance to nalidixic acid and new 4-quinolones?
    Crumplin GC
    Lancet; 1987 Oct; 2(8563):854-5. PubMed ID: 2889052
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of conjugal transfer by new quinolinic compounds.
    Oliva B; Selan L; Ravagnan G; Renzini G
    Chemioterapia; 1985 Jun; 4(3):199-201. PubMed ID: 3161641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].
    Thibault M; Koumaré B; Soussy CJ; Duval J
    Ann Microbiol (Paris); 1981; 132(3):267-81. PubMed ID: 6457546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evolution of quinolone: from nalidixic acid to the quinolones of the third generation].
    Petersen U
    Pharm Unserer Zeit; 2001; 30(5):376-81. PubMed ID: 11575173
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physico-chemical properties and biological activities of erythromycin nalidixate.
    Goswami BB; Manna PK; Basu SK
    Arzneimittelforschung; 1995 Jul; 45(7):813-4. PubMed ID: 8573228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acrosoxacin (rosoxacin) sensitivity of Neisseria strains].
    Fuzi M
    Orv Hetil; 1984 Apr; 125(17):1005-7. PubMed ID: 6425763
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quinolone resistance in Salmonella enterica].
    Seral C; López L; Castillo FJ; Clavel A; Rubio MC
    Rev Esp Quimioter; 1998 Mar; 11(1):43-6. PubMed ID: 9795288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin (BAY O 9867). Comparative in vitro activity study.
    Canton E; Garcia J; Vila B; Santos M; Gobernado M
    Microbiol Esp; 1984; 37(3-4):73-9. PubMed ID: 6242123
    [No Abstract]   [Full Text] [Related]  

  • 13. In-vitro activity of antifungal agents in combination with four quinolones.
    Petrou MA; Rogers TR
    Drugs Exp Clin Res; 1988; 14(1):9-18. PubMed ID: 3292181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
    Scazzocchio F; Selan L; Oliva B; Schippa S; Cellini L; Renzini G
    Chemioterapia; 1988 Oct; 7(5):295-7. PubMed ID: 3066516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium.
    Ruiz J; Castro D; Goñi P; Santamaria JA; Borrego JJ; Vila J
    J Med Microbiol; 1997 Jul; 46(7):623-8. PubMed ID: 9236748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new quinolone (pefloxacine) in bronchopulmonary superinfections in cystic fibrosis].
    Reineri P; Squinazi F; Tobelem R; Lemerle S; Lobut JB; Bernaudin F; Kohout G; Bouveret
    Pediatrie; 1984; 39(7):597-8. PubMed ID: 6598489
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospects for new antibiotics: keeping one step ahead.
    Greenwood D
    J R Coll Physicians Lond; 1985 Oct; 19(4):231-4. PubMed ID: 4067896
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging quinolone-resistant Salmonella in the United States.
    Herikstad H; Hayes P; Mokhtar M; Fracaro ML; Threlfall EJ; Angulo FJ
    Emerg Infect Dis; 1997; 3(3):371-2. PubMed ID: 9284384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
    Joly-Guillou ML; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nalidixic acid-resistant Salmonella typhi in Mumbai.
    Rodrigues C; Mehta A; Joshi VR
    Natl Med J India; 1999; 12(2):88. PubMed ID: 10416332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.